Dr. Jonathan Wang has close to 30 years of healthcare and life sciences experience, spanning entrepreneurship, investment, research and finance. Under the supervision of Eric Kandel, a Nobel Laureate, he obtained a Ph.D. in Neurobiology from Columbia University where he was rewarded the Howard Hughes Medical Institute (HHMI) Research Fellowship. He also earned an MBA from Stanford University.
Dr. Wang was a Partner at OrbiMed, the world’s largest healthcare-dedicated investment firm，where he co-founded OrbiMed Asia. He has been named one of the top 10 healthcare investors in China. He is Chairman and CEO at Inmagene Biopharmaceuticals, and former Chairman at Apollomics and Angelalign.
He is a HKEX Biotech Advisory Panel member and a co-founder and former Chairman of BayHelix, a premier organization of Chinese healthcare business leaders. He has authored two philosophy of science books and is a columnist at a Chinese newspaper Popular Science Times.